advanced search

CONNECTIVITY

THE SMART INHALER REVOLUTION: ARE WE THERE YET?
CONNECTIVITY
Dr Mark Allen
Cambridge Design Partnership
THE SMART INHALER REVOLUTION: ARE WE THERE YET?
Mark Allen, David Blakey and Karla Sanchez discuss the benefits of smart inhalers and how they could influence the commercialisation of respiratory drugs in the future.
HOW DIGITAL THERAPEUTICS ADD VALUE TO TREATMENTS FOR COMPLEX CONDITIONS
CONNECTIVITY
Romain Marmot
Aptar Digital Health
HOW DIGITAL THERAPEUTICS ADD VALUE TO TREATMENTS FOR COMPLEX CONDITIONS
Romain Marmot discusses how external partners with a track record of developing digital therapeutics for numerous chronic conditions and therapies can help life science organisations implement digital solutions across their pipeline, adding value to each therapy while improving medication adherence and clinical outcomes.
HOW DIGITAL UX IN CLINICAL TRIALS CAN IMPROVE MEASURES
EXPERT VIEW
Dr Ben Cox
HOW DIGITAL UX IN CLINICAL TRIALS CAN IMPROVE MEASURES
Ben Cox discusses the key challenges, principles and advantages of following a user-experience approach to digital health technologies in clinical trials.
HOW RECENT NFC ADVANCES ENABLE ANTI-COUNTERFEIT DRUG CONTAINMENT & SUPPORT ADHERENCE
EXPERT VIEW
Sylvia Kaiser
HOW RECENT NFC ADVANCES ENABLE ANTI-COUNTERFEIT DRUG CONTAINMENT & SUPPORT ADHERENCE
Sylvia Kaiser-Kershaw discusses how recent near-field communication tagging advancements can enable pharmaceutical companies to protect the authenticity and integrity of their products, while also making it easier for healthcare professionals and patients to use medications more effectively through intelligent drug delivery systems.
NO TYPE: AN APP TO PREDICT PATIENTS’ LIKELIHOOD TO TAKE MEDICATION AS PRESCRIBED
EARLY INSIGHT
Louisa Harvey
No Type
NO TYPE: AN APP TO PREDICT PATIENTS’ LIKELIHOOD TO TAKE MEDICATION AS PRESCRIBED
Louisa Harvey, Alper Hulusi, Bjarki Holm and Stefan Olafsson introduce their quick and accessible app for identifying whether or not a patient is likely to take their medication as prescribed.
CYBERSECURITY AND THE CHALLENGES OF CLOUD CONNECTIVITY
EXPERT VIEW
Gabrielle Whitworth-Smith
CYBERSECURITY AND THE CHALLENGES OF CLOUD CONNECTIVITY
Gabrielle Whitworth-Smith and Thomas Watts look at the benefits and risks associated with cloud connectivity and the accompanying cybersecurity challenges.
CONNECTIVITY IN HEALTHCARE – FROM THE MILLENNIUM TO THE PANDEMIC AND BEYOND
EXPERT VIEW
Napoleon Monroe
CONNECTIVITY IN HEALTHCARE – FROM THE MILLENNIUM TO THE PANDEMIC AND BEYOND
Napoleon Monroe looks back at the factors that influenced the underwhelming uptake of connectivity-enabling technologies in the healthcare sector over the first two decades of the 21st century, how the covid-19 pandemic changed everything and what current healthcare challenges connectivity might solve.
SUPPORTING PATIENTS ON THE ROAD TO SELF-CARE
CONNECTIVITY
Michael Earl
Owen Mumford
SUPPORTING PATIENTS ON THE ROAD TO SELF-CARE
Michael Earl discusses the importance of transitioning current healthcare models to embrace patient self-management and how advanced drug delivery device technologies, such as connectivity, can ease this burden on overstretched healthcare services.
SMART DRUG DELIVERY DEVICES IMPROVE MEDICATION ADHERENCE: HERE’S HOW
EXPERT VIEW
Paul Edalat
SMART DRUG DELIVERY DEVICES IMPROVE MEDICATION ADHERENCE: HERE’S HOW
Paul Edalat and Mehdi Hatamian take an in-depth look at medication non-adherence and how technology can be used to improve compliance rates and optimise patient outcomes.
INJECTING THE FUTURE
INJECTION
Simone Farina
Flex
INJECTING THE FUTURE
Simone Farina discusses Flex’s new smart autoinjector platform for the healthcare market, designed to enable original equipment manufacturers to accelerate time-to-market, reduce costs and boost reliability, while ensuring patient compliance.
CONNECTED DRUG DELIVERY – MAXIMISING ACCESS BY DESIGN
CONNECTIVITY
Dr Oliver Eden
Jabil Healthcare
CONNECTED DRUG DELIVERY – MAXIMISING ACCESS BY DESIGN
Oliver Eden discusses the factors that drive the design and development of a reusable autoinjector solution. Foremost amongst these considerations is the patient, in terms of ease of use with the device itself and maximising access to the broadest possible population with a versatile, portfolio-enabling platform ready for the connected world.
EXCELLENCE THROUGH SIMPLICITY: PICCOJECT™ AUTOINJECTOR PLATFORM
INJECTION
Dr Fred Metzmann
Haselmeier
EXCELLENCE THROUGH SIMPLICITY: PICCOJECT™ AUTOINJECTOR PLATFORM
Fred Metzmann and Chris Muenzer discuss the simplicity of the PiccoJect™ autoinjector platform and the company's commitment to sustainability.
SUSTAINABILITY: WHAT CAN THE HEALTHCARE SECTOR LEARN FROM CONSUMER DESIGN?
SUSTAINABILITY
Fran Pencliffe
Cambridge Design Partnership
SUSTAINABILITY: WHAT CAN THE HEALTHCARE SECTOR LEARN FROM CONSUMER DESIGN?
Fran Penrose considers the lessons the healthcare sector can draw from the fast-moving consumer sector when designing for sustainability and asks, “Can we go even further?”
WAITING WITH BATED BREATH – WHAT’S IN STORE FOR 2022
EXPERT VIEW
Rob Udale
WAITING WITH BATED BREATH – WHAT’S IN STORE FOR 2022
Rob Udale and Heather Jameson discuss the exciting developments taking place in the design of inhalation devices and share their predictions for the top five inhalation trends to watch as 2022 unfolds, and beyond.
VOICE-ACTIVATED USER INTERFACES IN DRUG DELIVERY DEVICES CAN ENHANCE COMPLIANCE AND OUTCOMES
EXPERT VIEW
Salvatore Forte
VOICE-ACTIVATED USER INTERFACES IN DRUG DELIVERY DEVICES CAN ENHANCE COMPLIANCE AND OUTCOMES
Salvatore Forte looks at the evolution of voice-activated interfaces in medical devices, particularly autoinjectors, and the advantages for patient compliance and quality of care.
HOW MINIATURISED LIQUID FLOW SENSORS ARE REVOLUTIONISING SUBCUTANEOUS DRUG DELIVERY
CONNECTIVITY
Dr Andreas Alt
Sensirion
HOW MINIATURISED LIQUID FLOW SENSORS ARE REVOLUTIONISING SUBCUTANEOUS DRUG DELIVERY
Andreas Alt and Susanne Pianezzi describe the drivers accelerating industry trends towards both wearable subcutaneous injection devices and connecting such devices to monitor patient dosing, providing a number of benefits.
“SOFTWARE AS A MEDICAL DEVICE” FROM A HUMAN FACTORS PERSPECTIVE
EXPERT VIEW
Natalie Shortt
“SOFTWARE AS A MEDICAL DEVICE” FROM A HUMAN FACTORS PERSPECTIVE
Natalie Shortt discusses the considerations and steps to take when planning usability engineering efforts for software as a medical device.
TOWARDS A NEW STANDARD OF CARE WITH APTAR PHARMA’S DIGITAL HEALTH
CONNECTIVITY
Adam Shain
Aptar Pharma
TOWARDS A NEW STANDARD OF CARE WITH APTAR PHARMA’S DIGITAL HEALTH
Adam Shain discusses how Aptar is building on the progress made in connected drug delivery devices to help realise their full potential by developing an open, end-to-end platform that will enable healthcare stakeholders to take a holistic view of the full drug delivery journey.
MATERIAL SELECTION FOR NEXT-GENERATION CONNECTED MEDICAL ELECTRONICS
CONNECTIVITY
Miriam Kingsley
Victrex
MATERIAL SELECTION FOR NEXT-GENERATION CONNECTED MEDICAL ELECTRONICS
Miriam Kingsley, Marcus Jarman-Smith and Thomas Billings highlight the growing array of applications for high-performance polymers in electronic and connected medical devices and how proper material selection is crucial, providing a guide to successful material selection, going on to showcase its APTIV™ PEEK polymer film, which is well suited to meet the specific demands of next-generation connected medical devices.
eFLOW TECHNOLOGY NEBULISERS WITH DIGITAL THERAPY MANAGEMENT: THE PARI CONNECT ECO-SYSTEM
CONNECTIVITY
Dr Carola Fuchs
PARI
eFLOW TECHNOLOGY NEBULISERS WITH DIGITAL THERAPY MANAGEMENT: THE PARI CONNECT ECO-SYSTEM
Carola Fuchs and Simon Buchner describe PARI’s new nebuliser and digital Connect eco-system and how it supports patients, directly and indirectly, through carefully considered device usability in combination with digital therapy management solutions.
Interview: Arnaud Guillet, Biocorp
INTERVIEW
Arnaud Guillet
Biocorp
Interview: Arnaud Guillet, Biocorp
In this exclusive interview with ONdrugDelivery, Arnaud Guillet discusses Mallya, Biocorp’s connected clip-on for pen injectors, including Mallya’s successful launch in multiple countries this year, the factors that have played into the device’s success, and the future for Mallya, Biocorp and connectivity in the drug delivery industry.
YPSOMATE ON – GO FOR SIMPLY CONNECTED
CONNECTIVITY
Philippe Müller
Ypsomed
YPSOMATE ON – GO FOR SIMPLY CONNECTED
Philippe Müller and Silas Mächler discuss the benefits of integrated digital therapy management systems and the role of YpsoMate On –  the newest addition to Ypsomed’s connected device portfolio, and the world’s first prefilled autoinjector with integrated connectivity that automatically logs injections on the user’s therapy management app.
TRIALS WITHOUT TRIBULATIONS: A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED AND HYBRID CLINICAL TRIALS
CONNECTIVITY
Rebecca Beck
BD (Becton Dickinson & Company)
TRIALS WITHOUT TRIBULATIONS: A PATIENT-CENTRIC, CONNECTED INJECTION DEVICE FOR DECENTRALISED AND HYBRID CLINICAL TRIALS
Rebecca Beck and Hervé Monchoix discuss how stakeholder needs are driving the development of a new, connected injection device from BD, to support decentralised and hybrid clinical trials.
USING BLOCKCHAIN AND DATA ANALYTICS FOR IMPROVED MEDICAL CANNABIS EFFICACY
EARLY INSIGHT
Brad Moore
USING BLOCKCHAIN AND DATA ANALYTICS FOR IMPROVED MEDICAL CANNABIS EFFICACY
Brad Moore and Tim Morch describe GCAC’s technology offering, a blockchain-based software system that is able to transparently track the progress of medical cannabis from cultivation through to consumption.
Top